The Rise of Sustainable Packaging in Telemedicine and Mail-Order Pharmacies

The COVID-19 pandemic accelerated a fundamental shift in modern healthcare, accelerating the transition from brick and mortar retail pharmacies and into the digital space. Today, telemedicine and mail-order pharmacies are focusing on changing how patients receive care and also raising awareness about how medications are packaged and delivered sustainably.

What Is Telemedicine and Mail-Order Pharmacy?

Telemedicine is the digital management and remote delivery of prescription medications, enabled by platforms that allow patients to consult a doctor, receive a diagnosis, and get a prescription fulfilled without visiting a physical clinic.

Mail-order pharmacies are the fulfillment backbone of this model. Rather than collecting medications in person, patients receive their prescriptions directly at their door, shipped by licensed pharmacies in pre-sorted, pre-labeled packages.

Together, these two systems have created a growing pharmaceutical delivery pipeline.

The Benefits of Going Remote

Telemedicine and mail-order pharmacy delivery offer measurable advantages for both patients and healthcare systems including: 

• Improved access for patients in rural areas or with limited mobility can receive prescriptions without visiting a clinic.
• Safety and convenience with remote consultations and home delivery, reducing the exposure to infectious diseases and eliminating travel time.
• Specialist access to patients that can connect with specialists regardless of geographic location.
• Easier chronic disease management with wearable devices and health apps enabling continuous monitoring of conditions such as diabetes and cardiovascular disease.

The Packaging Problem

However, the rapid growth of telemedication has also caused a significant pharmaceutical packaging waste crisis. Packaging waste in the pharmaceutical industry has historically generated 300 million tonnes of plastic waste annually, with half originating from single-use packaging solutions. Medications account for approximately 20% of healthcare's carbon footprint, with nearly half of that impact tied directly to packaging. 

As far back as 2018, a single American chain pharmacy consumed 54,500 tons of paper across bags, labels, receipts, and patient information sheets, enough to fill roughly 2,500 truckloads. As mail-order volumes scale further, the net amount of packaging required to fulfill prescriptions will continue to increase, making the case for sustainable packaging as a business and environmental imperative even stronger. 

The sustainable pharmaceutical packaging market is projected to grow from USD 95.3 billion in 2025 to USD 214.1 billion by 2030, at a CAGR of 14.60%. Recyclable systems currently dominate with a 52.3% market share, while biodegradable and compostable formats are emerging as the fastest-growing segment, projected at a 14.20% CAGR through 2030. 

Numbers and studies prominently show a market shifting toward solutions that balance product integrity with environmental responsibility. The pharmaceutical industry, as one of the largest contributors to packaging waste, has both the responsibility and the commercial incentive to lead that change.

Sustainable Packaging Solutions in Mail-Order Pharmacy

The materials and approaches transforming pharmaceutical delivery available in the market includes:

• Recycled and Recyclable Paperboard: Transitioning to folding boxboard from standard bleached sulphate board can reduce packaging carbon footprint by over 50%, while replacing coated recycled board can yield reductions of 60% or more. 
• Compostable Mailers and Fillers: Paper-based and plant-derived alternatives to plastic bubble wrap and foam inserts that decompose without leaving toxic residue.
• Lightweighting: Right-sized packaging design that reduces material consumption and lowers freight emissions per shipment.
• Post-Consumer Resin (PCR) Plastics: Plastics derived from previously recycled consumer materials, reducing dependence on virgin plastic production.

These materials are commercially available and are proven solutions that the industry is actively adopting under increasing regulatory pressure. Governments and multilateral institutions are mandating recyclable or biodegradable materials and accelerating the phase-out of single-use plastics across pharmaceutical supply chains, making the transition evident.

Industry Moving Into Action

Penn Medicine, one of the most respected and influential health systems in the United States, has made a landmark commitment to sustainability by partnering with Parcel Health for a system-wide transition to paper pill packaging. The rollout marks a significant milestone, demonstrating that highly regulated health systems are willing to move decisively on sustainability. 

Parcel Health as Part of the Solution

Our paper-based Tully Tubes, represent a direct replacement for conventional plastic pill packaging without compromising medication integrity or patient safety. Our next wave of solutions, including mailers, baggies and the Maggie Box, are already in active use with select pharmaceutical partners ahead of our official launch, further expanding what paper-based pharmaceutical packaging can achieve across different delivery formats.

We actively work with mail-order pharmacies, telehealth platforms, and pharmaceutical distributors like Shameless, Good Life Meds, TelyRx and more to move away from single-use plastics at every stage of the fulfillment chain. From individual dose packaging to cold-chain delivery, our products are designed to protect medications in transit while meaningfully reducing the environmental burden on the supply chain.

The Penn Medicine partnership signals where the industry is heading. As more health systems, mail-order operators, and pharmaceutical distributors commit to sustainable fulfillment, Parcel Health is ready to support that transition. Learn more about moving your pharmaceutical supply chain toward a sustainable future at www.parcelhealth.co

‍